Ozempic (semaglutide) was originally FDA-approved in 2017 for the management of Type 2 diabetes. Clinical evidence quickly revealed something significant alongside its primary indication: patients using it were also losing substantial body weight. That observation drove the development of Wegovy—a higher-dose semaglutide formulation approved specifically for chronic weight management—and contributed to the broader recognition of GLP-1 receptor agonists as a breakthrough category in obesity treatment.

How Ozempic Supports Weight Loss

Ozempic works by mimicking GLP-1, a gut hormone produced after eating. It signals the brain that the body is full, slows gastric emptying so you remain satisfied for longer, and stimulates appropriate insulin release in response to meals. The combined effect reduces overall caloric intake without the constant conscious restriction that makes traditional diets difficult to sustain.

For patients whose weight challenges are driven by persistent hunger, difficulty feeling full, or blood sugar dysregulation, these mechanisms address the root causes rather than just the surface symptom. Clinical studies have shown that patients using semaglutide alongside lifestyle changes lose significantly more weight than those making lifestyle changes alone—and maintain a greater proportion of that loss over time.

What the Programme Involves

An Ozempic weight loss service built around proper clinical oversight begins with a comprehensive consultation. Health history, current medications, metabolic markers, and weight loss goals are all reviewed before any prescription is written. The starting dose is low—0.25 mg weekly—and increased gradually over months to optimise results and minimise early digestive side effects such as nausea.

Ongoing care includes regular follow-up appointments to review progress, adjust dosing where needed, and integrate lifestyle support covering dietary patterns, physical activity, and sleep quality. Body composition is monitored alongside scale weight to track real changes in fat and lean mass rather than just total body weight—a distinction that matters for both health and long-term programme design.

The Difference Physician Supervision Makes

Ozempic prescriptions are increasingly accessible through online platforms with minimal clinical evaluation. The limitation of that approach is not the medication itself—it is what surrounds it. Without ongoing physician oversight, dosing decisions are made without context, drug interactions go unchecked, and the lifestyle and behavioural components that sustain long-term results are absent. A properly managed Ozempic weight loss service includes all of those elements as standard, not as optional extras.

Ozempic Weight Loss Service with Adonis Saremi, MD

For patients in San Diego seeking an Ozempic weight loss service that combines genuine obesity medicine expertise with personalised, concierge-delivered care, Adonis Saremi, MD provides a programme where the medication is one part of a carefully managed clinical plan. Available via telemedicine for patients across California, in-office for Executive members, and as VIP in-home visits for the most comprehensive experience, the practice delivers the clinical depth and continuous physician access that an effective Ozempic programme requires. Adonis Saremi, MD‘s triple board certifications in Obesity Medicine, Internal Medicine, and Clinical Informatics ensure every prescription decision is grounded in specialist-level understanding of metabolic health.